In the Era of mpMRI and PSMA PET/CT: Does Digital Rectal Examination Still Matter?
Open Access
- 3 March 2026
- journal article
- Published by Wiley in The Prostate
- Vol. 86 (7) , 805-810
Abstract
Background: With the increasing integration of multiparametric MRI (mpMRI) and 68Ga‐PSMA PET/CT into the diagnostic and staging algorithms of prostate cancer (PCa), digital rectal examination (DRE)—a once foundational and cost‐effective physical examination—has gradually become marginalized in daily clinical practice. However, the continued relevance of DRE in the modern imaging era remains uncertain. This study aimed to reassess the diagnostic value of DRE in the context of contemporary imaging tools, particularly mpMRI and PSMA PET/CT. Methods: This retrospective analysis included 164 patients diagnosed with prostate adenocarcinoma via transrectal ultrasound‐guided biopsy. All patients underwent DRE before biopsy, and 151 received mpMRI while 62 underwent PSMA PET/CT. mpMRI findings were reported using PI‐RADS v2.1, and SUVmax values were recorded from PET/CT reports. Radical prostatectomy was performed in 156 patients. The relationship between DRE findings and imaging parameters, biopsy results, and pathological staging was analyzed using multivariate statistics and ROC curve analyses. Results: DRE findings were benign in 100 patients and suspicious for malignancy in 64. Suspicious DRE was significantly associated with higher PI‐RADS scores, greater lesion size, elevated SUVmax, and clinically significant PCa ( p < 0.001 for all). Each one‐point increase in PI‐RADS was associated with a twofold rise in the likelihood of a positive DRE. ROC analyses identified a 13.5 mm lesion size and an SUVmax of 15.1 as predictive thresholds for DRE positivity. Suspicious DRE also correlated with advanced pathological stage (≥ pT3) ( p < 0.001). Conclusion: Despite the rise of advanced imaging techniques, DRE remains a valuable adjunctive tool in identifying high‐risk and advanced PCa. When interpreted alongside mpMRI and PSMA PET/CT findings, DRE provides additional clinical insight, supporting its continued role in risk stratification rather than screening in the modern diagnostic workflow.Keywords
This publication has 29 references indexed in Scilit:
- Correlation of Multiparametric MRI PIRADS Scoring with Histopathological Outcomes and Prognostic Significance in Prostate Cancer: A Tertiary Care Center StudyIndian Journal of Surgical Oncology, 2025
- The additional value of 68Ga‐PSMA PET/CT SUVmax in predicting ISUP GG ≥ 2 and ISUP GG ≥ 3 prostate cancer in biopsyThe Prostate, 2024
- The impact of pre‐biopsy MRI and additional testing on prostate cancer screening outcomes: A rapid reviewBJUI Compass, 2024
- Comparing the Performance of Digital Rectal Examination and Prostate-specific Antigen as a Screening Test for Prostate Cancer: A Systematic Review and Meta-analysisEuropean Urology Oncology, 2024
- Prognostic impact of palpable prostate tumors on disease progression after robot-assisted radical prostatectomy: a single-center experienceJournal of Robotic Surgery, 2023
- Diagnostic Performance of Prostate-specific Membrane Antigen Positron Emission Tomography–targeted biopsy for Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysisEuropean Urology Oncology, 2022
- Negative Biopsy Histology in Men With PI-RADS Score 5 in Daily Clinical Practice: Incidence of Granulomatous ProstatitisClinical Genitourinary Cancer, 2020
- Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective studyEuropean Radiology, 2013
- The Role of the Digital Rectal Examination in Subsequent Screening Visits in the European Randomized Study of Screening for Prostate Cancer (ERSPC), RotterdamEuropean Urology, 2008
- Incidence of Prostate Cancer in Sicily: Results of a Multicenter Case-Findings ProtocolEuropean Urology, 2005